Literature DB >> 20378682

Insufficient luteinizing hormone-induced intracellular signaling disrupts ovulation in preovulatory follicles lacking estrogen receptor-{beta}.

Karina F Rodriguez1, John F Couse, Friederike L Jayes, Katherine J Hamilton, Katherine A Burns, Fuminori Taniguchi, Kenneth S Korach.   

Abstract

Gonadotropin-stimulated estrogen receptor-beta (ERbeta)-null preovulatory follicles exhibit submaximal estradiol production, insufficient acquisition of LH receptor, and attenuated expression of essential ovulatory genes. These observations lead to low ovulatory rates compared with wild-type (WT) follicles. We hypothesize that insufficient LH receptor results in reduced cAMP production after an ovulatory stimulus. Individual preantral follicles were cultured with FSH for 4 d and then induced to ovulate with a single dose of human chorionic gonadotropin (hCG). cAMP levels 1 h after hCG were 50% lower in ERbeta-null than WT follicles. To determine whether the lack of LH receptor, and resulting lack of cAMP, could be bypassed by direct activation of adenylyl cyclase, WT and ERbeta-null follicles were induced to ovulate with forskolin. Ten micromolar forskolin doubled the ovulatory rate of ERbeta-null follicles compared with treatment with hCG ( approximately 50 vs. 25%, respectively). In WT follicles, 10 microm forskolin reduced the ovulation rate compared with hCG (14 vs. 83%, respectively), indicating that high doses of forskolin inhibited WT ovulation. A 10 microm concentration of forskolin induced cAMP levels in ERbeta-null follicles that were comparable to levels produced in WT follicles after hCG and either partially or completely rescued the attenuated expression of LH-responsive genes. These data indicate that direct activation of adenylyl cyclase, resulting in increased production of cAMP, partially rescues the ovulatory response of ERbeta-null follicles, suggesting that insufficient LH receptor and low cAMP levels contribute to their poor ovulatory rates. We also determined that ERbeta-null ovaries exhibit an alteration in the activation of ERK1/2. Our evaluation of the ERbeta-null ovarian phenotype indicates that ERbeta plays a role in facilitating folliculogenesis. We show that expression of ERbeta in preovulatory follicles is required for adequate cAMP production and propose that an optimal level of cAMP is required for hCG-stimulated ovulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20378682      PMCID: PMC2875826          DOI: 10.1210/en.2009-1446

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  28 in total

1.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

2.  EGF-like growth factors as mediators of LH action in the ovulatory follicle.

Authors:  Jy-Young Park; You-Qiang Su; Miyako Ariga; Evelyn Law; S-L Catherine Jin; Marco Conti
Journal:  Science       Date:  2004-01-15       Impact factor: 47.728

Review 3.  New signaling pathways for hormones and cyclic adenosine 3',5'-monophosphate action in endocrine cells.

Authors:  J S Richards
Journal:  Mol Endocrinol       Date:  2001-02

4.  Adenylyl cyclase activities in ovarian tissues. II. Regulation of responsiveness to LH, FSH, and PGE1 in the rabbit.

Authors:  M Hunzicker-Dunn; L Birnbaumer
Journal:  Endocrinology       Date:  1976-07       Impact factor: 4.736

5.  Preovulatory luteinization during induction of follicular maturation with menotrophin and menotrophin--clomiphene combination.

Authors:  A Birkenfeld; S Mor-Joseph; J Ezra; A Simon; D Navot
Journal:  Hum Reprod       Date:  1990-07       Impact factor: 6.918

6.  Hormonal regulation of luteinizing hormone/chorionic gonadotropin receptor mRNA in rat ovarian cells during follicular development and luteinization.

Authors:  D L Segaloff; H Y Wang; J S Richards
Journal:  Mol Endocrinol       Date:  1990-12

7.  Clinical evidence for an LH 'ceiling' effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation.

Authors:  Ernest Loumaye; Patrick Engrand; Zeev Shoham; Stephen G Hillier; David T Baird
Journal:  Hum Reprod       Date:  2003-02       Impact factor: 6.918

8.  Estrogen receptor beta is required for optimal cAMP production in mouse granulosa cells.

Authors:  Bonnie J Deroo; Karina F Rodriguez; John F Couse; Katherine J Hamilton; Jennifer B Collins; Sherry F Grissom; Kenneth S Korach
Journal:  Mol Endocrinol       Date:  2009-03-26

9.  Autocrine role of estrogens in the augmentation of luteinizing hormone receptor formation in cultured rat granulosa cells.

Authors:  B Kessel; Y X Liu; X C Jia; A J Hsueh
Journal:  Biol Reprod       Date:  1985-06       Impact factor: 4.285

10.  Aromatase inhibitors prevent granulosa cell differentiation: an obligatory role for estrogens in luteinizing hormone receptor expression.

Authors:  M Knecht; A M Brodie; K J Catt
Journal:  Endocrinology       Date:  1985-09       Impact factor: 4.736

View more
  16 in total

1.  Estrogen promotes the development of mouse cumulus cells in coordination with oocyte-derived GDF9 and BMP15.

Authors:  Koji Sugiura; You-Qiang Su; Qinglei Li; Karen Wigglesworth; Martin M Matzuk; John J Eppig
Journal:  Mol Endocrinol       Date:  2010-11-03

2.  Development and Characterization of Novel Rat Anti-mERβ Sera.

Authors:  Horacio J Novaira; J B Graceli; S Capellino; A Schoeffield; G E Hoffman; A Wolfe; F Wondisford; S Radovick
Journal:  Endocrinology       Date:  2016-04-22       Impact factor: 4.736

3.  The naturally occurring luteinizing hormone surge is diminished in mice lacking estrogen receptor Beta in the ovary.

Authors:  Friederike L Jayes; Katherine A Burns; Karina F Rodriguez; Grace E Kissling; Kenneth S Korach
Journal:  Biol Reprod       Date:  2014-02-06       Impact factor: 4.285

4.  Role of estrogen receptor signaling required for endometriosis-like lesion establishment in a mouse model.

Authors:  Katherine A Burns; Karina F Rodriguez; Sylvia C Hewitt; Kyathanahalli S Janardhan; Steven L Young; Kenneth S Korach
Journal:  Endocrinology       Date:  2012-06-14       Impact factor: 4.736

5.  Defining the Role of Estrogen Receptor β in the Regulation of Female Fertility.

Authors:  M A Karim Rumi; Prabhakar Singh; Katherine F Roby; Xiao Zhao; Khursheed Iqbal; Anamika Ratri; Tianhua Lei; Wei Cui; Shaon Borosha; Pramod Dhakal; Kaiyu Kubota; Damayanti Chakraborty; Jay L Vivian; Michael W Wolfe; Michael J Soares
Journal:  Endocrinology       Date:  2017-07-01       Impact factor: 4.736

Review 6.  Estrogen Hormone Biology.

Authors:  Katherine J Hamilton; Sylvia C Hewitt; Yukitomo Arao; Kenneth S Korach
Journal:  Curr Top Dev Biol       Date:  2017-02-03       Impact factor: 4.897

7.  Follicle-stimulating hormone and luteinizing hormone increase Ca2+ in the granulosa cells of mouse ovarian follicles†.

Authors:  Jeremy R Egbert; Paul G Fahey; Jacob Reimer; Corie M Owen; Alexei V Evsikov; Viacheslav O Nikolaev; Oliver Griesbeck; Russell S Ray; Andreas S Tolias; Laurinda A Jaffe
Journal:  Biol Reprod       Date:  2019-08-01       Impact factor: 4.285

Review 8.  Regulation of Mammalian Oocyte Meiosis by Intercellular Communication Within the Ovarian Follicle.

Authors:  Laurinda A Jaffe; Jeremy R Egbert
Journal:  Annu Rev Physiol       Date:  2016-11-14       Impact factor: 19.318

9.  The absence of ER-β results in altered gene expression in ovarian granulosa cells isolated from in vivo preovulatory follicles.

Authors:  April K Binder; Karina F Rodriguez; Katherine J Hamilton; Patricia S Stockton; Casey E Reed; Kenneth S Korach
Journal:  Endocrinology       Date:  2013-04-11       Impact factor: 4.736

10.  De Novo-Synthesized Retinoic Acid in Ovarian Antral Follicles Enhances FSH-Mediated Ovarian Follicular Cell Differentiation and Female Fertility.

Authors:  Tomoko Kawai; Noriyuki Yanaka; JoAnne S Richards; Masayuki Shimada
Journal:  Endocrinology       Date:  2016-03-29       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.